“I am excited to join Envisagenics at this pivotal stage in the company’s development,” said Sudhir Rao. “The company’s cutting-edge, AI-driven SpliceCore® platform identifies novel targets, paving the way for innovative treatments in oncology, neurodegenerative diseases, and beyond. I look forward to collaborating with the talented team to execute impactful partnerships, expand our relationships with investors and enable the development of groundbreaking therapies for patients.”

Vincent Renz has served most recently as the President and Founder of Straight4ward Advisory Services – a boutique professional services company. He is experienced with driving significant value creation for shareholders and delivering on both turnaround and growth strategies. In 2024, Renz joined Brand Craft Holdings in an advisory capacity to begin building the team to identify investment opportunities.

In this new role, Rob Wojciechowski will oversee the company’s strategic initiatives across its regulatory, quality, and compliance practice areas, further positioning ELIQUENT to meet the growing global demand for integrated regulatory, quality, and safety solutions across diverse markets.

Dr. Walker, a globally recognized key opinion leader, joins Peytant Solutions with a distinguished combination of clinical practice, medical research, and product development experience and will oversee all current and future clinical applications of Peytant’s initial flagship product, the AMStent® Tracheobronchial Covered Stent System.